Related Experiment Videos
Shifting paradigms in tumor metastasis: challenges and opportunities
J Thomas Parsons1, Bruce Zetter, Suresh Mohla
1Department of Microbiology, University of Virginia Health System, Charlottesville, VA, USA. jtp@virginia.edu
Cancer Biology & Therapy
|December 24, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Inhibition of Wnt Signaling in Colon Cancer Cells via an Oral Drug that Facilitates TNIK Degradation.
Molecular cancer therapeutics·2022
Prohibitin regulates mTOR pathway via interaction with FKBP8.
Frontiers of medicine·2020
The molecular mechanisms of platelets in tumor invasion and metastasis: a controversial role.
Cancer biology & therapy·2026
Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics.
Cancer biology & therapy·2026
DNA polymerase theta (Polθ): a novel candidate for targeted cancer therapy.
Cancer biology & therapy·2026
Targeting molecular and genetic pathways driving tumorigenesis for precision therapy in colorectal cancer.
Cancer biology & therapy·2026
Bis-(di-4-phenyl-benzylaminethiocarbonyl)disulfide sensitizes ABCC2/ALDH3A1 overexpressing NSCLC cells to cisplatin.
Cancer biology & therapy·2026
A Phase 2 Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 Amplified Cancers: A Non-Randomized Clinical Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Comparative Effectiveness of Combination Therapy in Patients with Chronic Kidney Disease and Diabetes mellitus Type 2 using Real World Data.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Efficacy and safety of durvalumab with or without tremelimumab in the treatment of metastatic non-small cell lung cancer: a meta-analysis of randomized controlled trials.
Proceedings (Baylor University. Medical Center)·2026